Leaflet INFANRIX HIB lyophilisate and suspension for suspension for injection
Indicated for: active immunization
Route of administration: injectable
Substance: DTPA + HIB combination vaccine (vaccine)
ATC: J07AG52 (Antiinfectives for systemic use | Bacterial vaccines | Haemophilus influenzae B vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The combined DTPa + Hib vaccine is used to immunize children against four serious infectious diseases: diphtheria, tetanus, pertussis (whooping cough), and infections caused by Haemophilus influenzae type b (Hib). This combined vaccine provides effective protection and reduces the number of injections required in the vaccination schedule.
- Diphtheria is a bacterial infection that can affect the throat and airways, causing breathing difficulties and severe complications.
- Tetanus is a disease caused by a bacterial toxin that affects the nervous system, leading to severe and potentially fatal muscle spasms.
- Pertussis (whooping cough) is a highly contagious respiratory infection that can cause severe coughing fits, breathing difficulties, and serious complications, especially in infants.
- Haemophilus influenzae type b (Hib) is a bacterium that can cause severe infections such as meningitis, epiglottitis, and sepsis, particularly in young children.
The vaccine is administered via intramuscular injection, usually in the thigh or arm, according to the national vaccination schedule. It is recommended starting at 2 months of age, with multiple doses given at specific intervals.
Side effects are usually mild and include redness, swelling, or pain at the injection site, mild fever, irritability, or fatigue. Severe reactions are rare. It is important to administer the vaccine as recommended by a healthcare provider, and parents should inform medical staff about any allergies or previous adverse reactions to vaccines.
General data about INFANRIX HIB
- Substance: DTPA + HIB combination vaccine
- Date of latest medicines list: 01-07-2013
- Product code: W13415001
- Pharmaceutical form: lyophilisate and suspension for suspension for injection
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.